MSD Korea, Daewoong sign co-promotion deal for Vytorin

MSD Korea and Daewoong Pharmaceuticals have recently entered into an agreement for the co-marketing of Vytorin for the treatment of high cholesterol in the domestic market following their strategic alliance of Foxamax tablets and Januvia tablets.

Vyrorin contains ezetimibe, a selective inhibitor of intestinal cholesterol and related phytosterol absorption, and simvastatin, an HMG-CoA reducta...